Does GLIVEC Cause Gastrointestinal stromal tumour? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Gastrointestinal stromal tumour have been filed in association with GLIVEC. This represents 4.0% of all adverse event reports for GLIVEC.
40
Reports of Gastrointestinal stromal tumour with GLIVEC
4.0%
of all GLIVEC reports
30
Deaths
12
Hospitalizations
How Dangerous Is Gastrointestinal stromal tumour From GLIVEC?
Of the 40 reports, 30 (75.0%) resulted in death, 12 (30.0%) required hospitalization.
Is Gastrointestinal stromal tumour Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLIVEC. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does GLIVEC Cause?
Death (628)
Malignant neoplasm progression (60)
Chronic myeloid leukaemia (38)
Anaemia (30)
Second primary malignancy (27)
Pyrexia (21)
Blast crisis in myelogenous leukaemia (20)
Dyspnoea (19)
Malaise (16)
Thrombocytopenia (16)
What Other Drugs Cause Gastrointestinal stromal tumour?
IMATINIB (899)
SUNITINIB MALATE (186)
RANITIDINE (184)
REGORAFENIB (108)
SUNITINIB (75)
LENALIDOMIDE (40)
VALSARTAN (35)
MYCOPHENOLATE MOFETIL (33)
NILOTINIB (33)
RITUXIMAB (33)
Which GLIVEC Alternatives Have Lower Gastrointestinal stromal tumour Risk?
GLIVEC vs GLOFITAMAB
GLIVEC vs GLOFITAMAB-GXBM
GLIVEC vs GLUCAGON
GLIVEC vs GLUCAGON\GLUCAGON\WATER
GLIVEC vs GLUCARPIDASE